← Back to headlines
AstraZeneca and Daiichi Sankyo Secure EU Approval for Breast Cancer Drug Datroway
AstraZeneca and Daiichi Sankyo have received label expansion approval from the European Union for their drug Datroway, to be used in the treatment of breast cancer.
31 Jul, 10:53 — 31 Jul, 10:53
Sources
Showing 1 of 1 sources
Related Stories
Review suggests heated tobacco may reduce exposure to harmful chemicals
just now
Hungarian Thermal Bath Operator Proposes Underground Water Solution for Drought
23m ago
Rethymno: DEDDIE Official Arrested Over Fatal Fire, Cable Sparks Under Investigation
26m ago
Bryan Johnson Expresses Doubts About Anti-Aging Experiment After Autoimmune Diagnosis
31m ago